 | | Health | September 16, 2016 |
Startup Highlight: DDPred
DDPred helps companies determine and manage the issues related to drug-drug interactions. Thanks to their new approach, they can quantitatively predict these interactions as well as the impact of CYP polymorphisms and cirrhosis. This helps to identify the most relevant clinical studies to conduct and better inform their design, during each phase of the drug development.
As always, if you come across news, announcements, videos, or podcasts that you think everyone else would benefit from, e-mail me at scott.munro@startupdigestmail.com or tweet @R_Scott_Munro.
Quote of the Week
"It seems to me we're at a point where a lot of interesting ideas remain interesting, but they were never meant to be companies. They were meant to be products, or parts of products, or parts of companies. And as valuations are coming down, which they are, and as access to capital is becoming a little more challenging and there's more need for evidence and proof that what you have is a legitimate solution big enough to be a company, you're going to see more and more of this type of M&A. Of small good ideas that were never meant to be standalone, rolled up into bigger projects, into bigger companies."
- Lisa Suennen, Managing Director, Cardeation Capital Management
| Health Startup Digest is curated by: |  | R. Scott Munro - MBA Candidate at the University of Chicago Booth School of Business Contact R. Scott Munro at scott.munro@startupdigestmail.com | How mobile commerce really works  Americans are now doing almost 33% of their online shopping on mobile devices. But what happens when you click “buy” isn’t as simple as it seems. A lot has to happen at lightning speed, with ironclad security, for mobile commerce to work. Check out this infographic, which lays out the entire process, by clicking here.
| Want to support diversity in tech?  Throughout September, Betabrand will donate $5 from every Dress Pant Yoga Pants purchase to the Techstars Foundation, a nonprofit working to improve diversity in technology entrepreneurship. | | Chrissy Farr - FastCo This is a great piece from Chrissy Farr on the various applications for AI in health care. She not only highlights 5 different applications, but names a number of companies working on problems from drug discovery to precision medicine. | | Zachary Brennan - Regulatory Affairs Professionals Society The UN released a report urging WTO members to, "no longer link the cost of research and development (R&D) with drug prices." While this may seem like a rather small point, many life sciences companies justify their prices by saying they fund further research on new drugs. As you can imagine, pharmaceutical companies are not pleased with this report, and many have suggested that implementing the suggestions in the report would slow down innovation and research. This, however, may not be the worst thing. As we have seen in the US, sometimes new drugs add cost to the system instead of taking it out. | | R. Scott Munro - 1776 This is a piece I wrote for 1776 on the Mylan/EpiPen controversy. I give a brief overview of some ways that the market is innovating around the price hikes to bring cheaper, better designed solutions to anaphylactic shock to the marketplace. | | HIT Consultant This is, of course, a fairly biased study; however, it is cool to see Walgreens roll out solutions to increase medication adherence. Now that these programs have been rolled out, Walgreens is saying they have demonstrated an increase in medication adherence. Of course, simple reminders only solve a portion of the adherence problem. Nonetheless, this is an interesting step into digital health from a new player in the space. | | Jonah Comstock - Mobihealth News This article goes into detail about some recent acquisitions in the digital health space, and insights from movers and shakers on what this means for the broader industry. The consensus is that we're at the beginning of a long series of acquisitions both of mid-sized startups acquiring new players, and traditional firms dipping their toes in the industry. Read more via the link above. | | Startup Health "Nathan Intrator, Professor of Computer Science and Founder of Neurosteer, talks about the progress his company has made in the development of new applications for brain monitoring, the impact home monitoring will have on patients and the general population, and Israel's evolving digital health ecosystem."
| | | You are receiving this email because you believe that the best startup articles and videos are made by active members of the startup community. Startup Digest, © 2009-2016 by Techstars Central LLC. All rights reserved. Startup Digest is a registered trademark of Techstars Central, LLC. Privacy Policy | Terms of Use. | |
| _rgb_600_51.png) |
|
No comments:
Post a Comment